309 related articles for article (PubMed ID: 29287216)
1. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
Sanmartí-Vilaplana F; Díaz-Gómez A
Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
[TBL] [Abstract][Full Text] [Related]
5. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
6. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.
Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H
Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy.
Miskin C; Khurana DS; Valencia I; Legido A; Hasbani DM; Carvalho KS
J Child Neurol; 2016 Jun; 31(7):925-8. PubMed ID: 26887412
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system.
Geitona M; Stamuli E; Giannakodimos S; Kimiskidis VK; Kountouris V; Charokopou M; Christou P
J Med Econ; 2019 Apr; 22(4):359-364. PubMed ID: 30652931
[TBL] [Abstract][Full Text] [Related]
13. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
[TBL] [Abstract][Full Text] [Related]
14. Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy.
Ishikawa N; Tateishi Y; Tani H; Kobayashi Y; Kobayashi M
Epilepsy Behav; 2019 May; 94():82-86. PubMed ID: 30897534
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies-An Italian observational multicenter study.
De Liso P; Vigevano F; Specchio N; De Palma L; Bonanni P; Osanni E; Coppola G; Parisi P; Grosso S; Verrotti A; Spalice A; Nicita F; Zamponi N; Siliquini S; Giordano L; Martelli P; Guerrini R; Rosati A; Ilvento L; Belcastro V; Striano P; Vari MS; Capovilla G; Beccaria F; Bruni O; Luchetti A; Gobbi G; Russo A; Pruna D; Tozzi AE; Cusmai R
Epilepsy Res; 2016 Nov; 127():93-100. PubMed ID: 27568598
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
Kurth C; Kockelmann E; Steinhoff BJ
Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
[TBL] [Abstract][Full Text] [Related]
18. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
[TBL] [Abstract][Full Text] [Related]
20. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
